Postmenopausal atrophic vaginitis
ICD-10 N95.2 is a billable code used to indicate a diagnosis of postmenopausal atrophic vaginitis.
Postmenopausal atrophic vaginitis is a condition characterized by the thinning, drying, and inflammation of the vaginal walls due to decreased estrogen levels following menopause. This condition can lead to various symptoms, including vaginal dryness, irritation, painful intercourse (dyspareunia), and urinary symptoms such as urgency and frequency. The atrophic changes in the vaginal epithelium can also increase susceptibility to infections. The onset of postmenopausal atrophic vaginitis typically occurs in women who have undergone menopause, which is defined as the cessation of menstrual periods for 12 consecutive months. The condition is often underreported due to the stigma associated with discussing sexual health issues, yet it significantly impacts the quality of life. Treatment options include vaginal moisturizers, lubricants, and estrogen therapy, which can help alleviate symptoms and restore vaginal health. Accurate coding of this condition is essential for appropriate management and reimbursement, as it reflects the need for targeted therapies and follow-up care.
Detailed patient history, including menopausal status, symptoms, and treatment plans.
Patients presenting with vaginal dryness, dyspareunia, or recurrent urinary tract infections post-menopause.
Ensure that the documentation reflects the chronic nature of the condition and any treatments provided.
Assessment of urinary symptoms and their relation to vaginal health.
Women experiencing urinary urgency or frequency alongside vaginal symptoms.
Document any urological evaluations performed to rule out other causes of urinary symptoms.
Used during follow-up visits for management of postmenopausal atrophic vaginitis.
Document the patient's symptoms, treatment response, and any changes in management.
Gynecologists should ensure that the visit focuses on reproductive health and symptom management.
Common symptoms include vaginal dryness, irritation, painful intercourse, and urinary symptoms such as urgency and frequency.
Treatment options include vaginal moisturizers, lubricants, and estrogen therapy to alleviate symptoms and restore vaginal health.
